Peptides
Sous-catégories appartenant à la catégorie "Peptides"
29704 produits trouvés pour "Peptides"
ZNF664 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF664 antibody, catalog no. 70R-9112Degré de pureté :Min. 95%SLC37A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC37A4 antibody, catalog no. 70R-6793Degré de pureté :Min. 95%FAM161A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM161A antibody, catalog no. 70R-10072Degré de pureté :Min. 95%PLEKHA9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PLEKHA9 antibody, catalog no. 70R-3896
Degré de pureté :Min. 95%TBCCD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TBCCD1 antibody, catalog no. 70R-3697Degré de pureté :Min. 95%CXCL9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CXCL9 antibody, catalog no. 70R-10497Degré de pureté :Min. 95%MED4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MED4 antibody, catalog no. 70R-8935Degré de pureté :Min. 95%CACNA2D1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CACNA2D1 antibody, catalog no. 70R-5102
Degré de pureté :Min. 95%SIL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SIL1 antibody, catalog no. 70R-7154Degré de pureté :Min. 95%HOMER1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HOMER1 antibody, catalog no. 70R-4400
Degré de pureté :Min. 95%NIT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NIT1 antibody, catalog no. 70R-2732Degré de pureté :Min. 95%ANKRD5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD5 antibody, catalog no. 70R-3386Degré de pureté :Min. 95%TRF3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRF3 antibody, catalog no. 20R-1177
Degré de pureté :Min. 95%C9ORF4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf4 antibody, catalog no. 70R-6868Degré de pureté :Min. 95%FAM134B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM134B antibody, catalog no. 70R-6834Degré de pureté :Min. 95%NNMT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NNMT antibody, catalog no. 70R-1262Degré de pureté :Min. 95%TRIB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRIB1 antibody, catalog no. 70R-3676Degré de pureté :Min. 95%DUSP12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DUSP12 antibody, catalog no. 70R-7952
Degré de pureté :Min. 95%KCNH6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNH6 antibody, catalog no. 70R-1513Degré de pureté :Min. 95%ESSPL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ESSPL antibody, catalog no. 70R-5488MAP4K2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAP4K2 antibody, catalog no. 70R-5783Degré de pureté :Min. 95%CSNK1A1L Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CSNK1A1L antibody, catalog no. 70R-9204Degré de pureté :Min. 95%PARD3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PARD3 antibody, catalog no. 70R-5678Degré de pureté :Min. 95%CAPS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CAPS antibody, catalog no. 70R-5864Degré de pureté :Min. 95%TMEM187 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM187 antibody, catalog no. 70R-7383Degré de pureté :Min. 95%P2RXL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of P2RXL1 antibody, catalog no. 70R-5077
Degré de pureté :Min. 95%PIK3R3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIK3R3 antibody, catalog no. 70R-1640Degré de pureté :Min. 95%TOM1L2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TOM1L2 antibody, catalog no. 70R-3299Degré de pureté :Min. 95%GPR177 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPR177 antibody, catalog no. 70R-6560Degré de pureté :Min. 95%MLC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MLC1 antibody, catalog no. 70R-5137Degré de pureté :Min. 95%Lgals4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Lgals4 antibody, catalog no. 70R-8534Degré de pureté :Min. 95%PHF12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PHF12 antibody, catalog no. 70R-8895Degré de pureté :Min. 95%SLC8A3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC8A3 antibody, catalog no. 70R-7350Degré de pureté :Min. 95%Pannexin 3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PANX3 antibody, catalog no. 70R-7072Degré de pureté :Min. 95%PSMD3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PSMD3 antibody, catalog no. 70R-9399Degré de pureté :Min. 95%Sideroflexin 3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SFXN3 antibody, catalog no. 70R-6635Degré de pureté :Min. 95%PDK2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PDK2 antibody, catalog no. 70R-2454
Degré de pureté :Min. 95%DKFZP564O0523 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DKFZP564O0523 antibody, catalog no. 70R-4970Degré de pureté :Min. 95%MCM4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MCM4 antibody, catalog no. 70R-1600Degré de pureté :Min. 95%CPSF3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CPSF3 antibody, catalog no. 70R-1413Degré de pureté :Min. 95%Hey1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Hey1 antibody, catalog no. 70R-7932
Degré de pureté :Min. 95%IFT172 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IFT172 antibody, catalog no. 70R-9095
Degré de pureté :Min. 95%ZNF607 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF607 antibody, catalog no. 70R-8098Degré de pureté :Min. 95%Hspb7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Hspb7 antibody, catalog no. 70R-8511
Degré de pureté :Min. 95%ZNF266 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF266 antibody, catalog no. 70R-8283
Degré de pureté :Min. 95%CYBA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CYBA antibody, catalog no. 70R-6483
Degré de pureté :Min. 95%Carboxylesterase 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CES1 antibody, catalog no. 70R-1213Degré de pureté :Min. 95%LAPTM4A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LAPTM4A antibody, catalog no. 70R-1814Degré de pureté :Min. 95%DNASE1L3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DNASE1L3 antibody, catalog no. 70R-10360Degré de pureté :Min. 95%ARPC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARPC3 antibody, catalog no. 70R-3073Degré de pureté :Min. 95%ENOPH1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ENOPH1 antibody, catalog no. 70R-3177Degré de pureté :Min. 95%SRD5A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SRD5A2 antibody, catalog no. 70R-6434Degré de pureté :Min. 95%C20ORF160 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C20orf160 antibody, catalog no. 70R-4133Degré de pureté :Min. 95%DONSON Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DONSON antibody, catalog no. 70R-1997Degré de pureté :Min. 95%NPTX2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NPTX2 antibody, catalog no. 70R-9388Degré de pureté :Min. 95%PDSS1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PDSS1 antibody, catalog no. 70R-2406Degré de pureté :Min. 95%PTPN11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTPN11 antibody, catalog no. 70R-9404
Degré de pureté :Min. 95%PODXL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PODXL2 antibody, catalog no. 70R-8671
Degré de pureté :Min. 95%DLL4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DLL4 antibody, catalog no. 70R-6414Degré de pureté :Min. 95%LOC339047 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LOC339047 antibody, catalog no. 70R-4291Degré de pureté :Min. 95%NAT2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NAT2 antibody, catalog no. 70R-6435Degré de pureté :Min. 95%LRRC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC3 antibody, catalog no. 70R-4456Degré de pureté :Min. 95%SOHLH2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SOHLH2 antibody, catalog no. 70R-8335Degré de pureté :Min. 95%NOTCH1 Blocking Peptide
The NOTCH1 Blocking Peptide is a highly effective and versatile peptide that plays a crucial role in various biochemical processes. It acts as an acetyltransferase and is commonly used in the field of Life Sciences for research purposes. This peptide has the unique ability to neutralize the activity of calmodulin, a protein involved in signal transduction pathways.Degré de pureté :Min. 95%EPS8L1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EPS8L1 antibody, catalog no. 70R-3570Degré de pureté :Min. 95%ZHX3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZHX3 antibody, catalog no. 70R-9571Degré de pureté :Min. 95%GMPPB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GMPPB antibody, catalog no. 70R-1204
Degré de pureté :Min. 95%TNRC18 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TNRC18 antibody, catalog no. 70R-9120Degré de pureté :Min. 95%9030625A04Rik Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of 9030625A04Rik antibody, catalog no. 70R-9217Degré de pureté :Min. 95%Tropomodulin 3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TMOD3 antibody, catalog no. 70R-3615Degré de pureté :Min. 95%PPP1R8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPP1R8 antibody, catalog no. 70R-1468Degré de pureté :Min. 95%MEPE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MEPE antibody, catalog no. 70R-8188Degré de pureté :Min. 95%BCKDK Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BCKDK antibody, catalog no. 70R-3675Degré de pureté :Min. 95%B4galt5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of B4galt5 antibody, catalog no. 70R-8656Degré de pureté :Min. 95%PTH2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTH2 antibody, catalog no. 70R-7505Degré de pureté :Min. 95%AChE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACHE antibody, catalog no. 70R-6078Degré de pureté :Min. 95%ALAS2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ALAS2 antibody, catalog no. 70R-2481Degré de pureté :Min. 95%DLG4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPP6 antibody, catalog no. 70R-6835Degré de pureté :Min. 95%Lamin B Receptor Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LBR antibody, catalog no. 70R-6757Degré de pureté :Min. 95%ATP8B2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP8B2 antibody, catalog no. 70R-4518
Degré de pureté :Min. 95%PCDHA4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PCDHA4 antibody, catalog no. 70R-6160Degré de pureté :Min. 95%SUPT16H Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SUPT16H antibody, catalog no. 20R-1066
Degré de pureté :Min. 95%DCBLD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DCBLD1 antibody, catalog no. 70R-6113Degré de pureté :Min. 95%CLEC4M Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC4M antibody, catalog no. 70R-6090
Degré de pureté :Min. 95%hCG_1982709 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_1982709 antibody, catalog no. 70R-9054Degré de pureté :Min. 95%BNIP1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BNIP1 antibody, catalog no. 70R-9801
Degré de pureté :Min. 95%DIRC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DVL1 antibody, catalog no. 70R-1639Degré de pureté :Min. 95%Transglutaminase 4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TGM4 antibody, catalog no. 70R-3924Degré de pureté :Min. 95%GK2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GK2 antibody, catalog no. 70R-9255Degré de pureté :Min. 95%NDUFS8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NDUFS8 antibody, catalog no. 70R-10376Degré de pureté :Min. 95%hCG_2007354 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of hCG_2007354 antibody, catalog no. 70R-9061Degré de pureté :Min. 95%FSTL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FSTL1 antibody, catalog no. 70R-9164Degré de pureté :Min. 95%NUP155 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUP155 antibody, catalog no. 70R-9235Degré de pureté :Min. 95%WDR33 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WDR33 antibody, catalog no. 70R-6953Degré de pureté :Min. 95%Sepn1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Sepn1 antibody, catalog no. 70R-8739Degré de pureté :Min. 95%KLF12 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KLF12 antibody, catalog no. 70R-7954Degré de pureté :Min. 95%TNRC6B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TNRC6B antibody, catalog no. 70R-4881Degré de pureté :Min. 95%TP53I13 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TP53I13 antibody, catalog no. 70R-9111Degré de pureté :Min. 95%RASGRP2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RASGRP2 antibody, catalog no. 70R-5804Degré de pureté :Min. 95%FAM62C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM62C antibody, catalog no. 70R-6915Degré de pureté :Min. 95%RAD23A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RAD23A antibody, catalog no. 70R-1037
Degré de pureté :Min. 95%SLC43A3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC43A3 antibody, catalog no. 70R-1888Degré de pureté :Min. 95%HERC6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HERC6 antibody, catalog no. 70R-2770
Degré de pureté :Min. 95%C16ORF78 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf78 antibody, catalog no. 70R-3350Degré de pureté :Min. 95%SLC7A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC7A1 antibody, catalog no. 70R-6772Degré de pureté :Min. 95%SRP14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SRP14 antibody, catalog no. 70R-1406
Degré de pureté :Min. 95%TCP11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TCP11 antibody, catalog no. 70R-3950
Degré de pureté :Min. 95%GC Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GC antibody, catalog no. 70R-10253Degré de pureté :Min. 95%FBXO5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO5 antibody, catalog no. 70R-2793
Degré de pureté :Min. 95%RAB34 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RAB34 antibody, catalog no. 70R-10114Degré de pureté :Min. 95%Afamin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AFM antibody, catalog no. 70R-5299Degré de pureté :Min. 95%Thrombopoietin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of THPO antibody, catalog no. 70R-6200Degré de pureté :Min. 95%NUP98 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NUP98 antibody, catalog no. 70R-5608Degré de pureté :Min. 95%FGF21 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FGF21 antibody, catalog no. 70R-6198Degré de pureté :Min. 95%SLC36A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC36A2 antibody, catalog no. 70R-6321Degré de pureté :Min. 95%RGS9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RGS9 antibody, catalog no. 70R-5843Degré de pureté :Min. 95%PTTG2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PTTG2 antibody, catalog no. 70R-8929Degré de pureté :Min. 95%Laminin Gamma 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LAMC1 antibody, catalog no. 70R-6061Degré de pureté :Min. 95%SF3B14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SF3B14 antibody, catalog no. 70R-4707Degré de pureté :Min. 95%POU5F1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POU5F1 antibody, catalog no. 70R-8464Degré de pureté :Min. 95%PPIA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIA antibody, catalog no. 70R-1077
Degré de pureté :Min. 95%Lipase Blocking Peptide (Pancreatic)
A synthetic peptide for use as a blocking control in assays to test for specificity of PNLIP antibody, catalog no. 70R-1591Degré de pureté :Min. 95%SV2A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SV2A antibody, catalog no. 70R-6572
Degré de pureté :Min. 95%TOB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TOB1 antibody, catalog no. 70R-9144Degré de pureté :Min. 95%AKR1B1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AKR1B1 antibody, catalog no. 70R-2252Degré de pureté :Min. 95%SLC6A8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC6A8 antibody, catalog no. 70R-7008Degré de pureté :Min. 95%SEC23IP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SEC23IP antibody, catalog no. 70R-9169
Degré de pureté :Min. 95%RNF128 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RNF128 antibody, catalog no. 70R-1873
Degré de pureté :Min. 95%HNRPUL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HNRPUL1 antibody, catalog no. 70R-4633Degré de pureté :Min. 95%FCRL4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FCRL4 antibody, catalog no. 70R-7228Degré de pureté :Min. 95%SLC25A16 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC25A16 antibody, catalog no. 70R-1748Degré de pureté :Min. 95%MUC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MUC1 antibody, catalog no. 70R-6968Degré de pureté :Min. 95%ZMYND17 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZMYND17 antibody, catalog no. 70R-8889
Degré de pureté :Min. 95%ABHD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ABHD2 antibody, catalog no. 70R-2941Degré de pureté :Min. 95%RPA4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RPA4 antibody, catalog no. 70R-5578Degré de pureté :Min. 95%ITGBL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ITGBL1 antibody, catalog no. 70R-1699Degré de pureté :Min. 95%Transglutaminase 2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TGM2 antibody, catalog no. 70R-6050Degré de pureté :Min. 95%FAM71D Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FAM71D antibody, catalog no. 70R-4980
Degré de pureté :Min. 95%CLEC6A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC6A antibody, catalog no. 70R-6646
Degré de pureté :Min. 95%HECTD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HECTD2 antibody, catalog no. 70R-2368
Degré de pureté :Min. 95%OR2L3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OR2L3 antibody, catalog no. 70R-9867Degré de pureté :Min. 95%DPH2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPH2 antibody, catalog no. 70R-3317Degré de pureté :Min. 95%ATP6V0D2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP6V0D2 antibody, catalog no. 70R-2659Degré de pureté :Min. 95%C17ORF57 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C17orf57 antibody, catalog no. 70R-3643Degré de pureté :Min. 95%SPP1 Blocking Peptide
The SPP1 Blocking Peptide is a highly effective tool for intracellular reactive oxygen detection. It is specifically designed to block the activity of a human enzyme, allowing for accurate and reliable results in Life Sciences research. This peptide can be used in various applications, including immunohistochemical detection and polymerase chain reactions. Its specific reactivity ensures precise targeting and inhibition of the enzyme, enabling researchers to study oxidative damage and its effects on cellular processes.Degré de pureté :Min. 95%MAGEB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEB1 antibody, catalog no. 70R-4381Degré de pureté :Min. 95%LUC7L Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LUC7L antibody, catalog no. 70R-9550Degré de pureté :Min. 95%SHMT2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SHMT2 antibody, catalog no. 70R-3206Degré de pureté :Min. 95%IFN Beta 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IFNB1 antibody, catalog no. 70R-4521
Degré de pureté :Min. 95%GALNT6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GALNT6 antibody, catalog no. 70R-7465Degré de pureté :Min. 95%TAL2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TAL2 antibody, catalog no. 70R-8270Degré de pureté :Min. 95%Kaliotoxin (1-37)
Kaliotoxin (1-37) is a peptide that is used as a research tool in cell biology and pharmacology. It has been shown to activate the glycine receptor and inhibit the potassium channel. Kaliotoxin (1-37) binds to the glycine receptor and activates it, which leads to an influx of calcium ions into the cell. This increases intracellular levels of calcium ions, which then activate other processes including protein synthesis and cell division.Formule :C165H271N53O48S8Degré de pureté :Min. 95%Masse moléculaire :4,021.8 g/molBromoacetamido-dPEG®12-Amido-DBCO
Bromoacetamido-dPEG®12-Amido-DBCO is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Bromoacetamido-dPEG®12-Amido-DBCO is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Degré de pureté :Min. 95%Masse moléculaire :996.98 g/molLipoamido-dPEG®12-TFP Ester
CAS :Lipoamido-dPEG®12-TFP Ester is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®12-TFP Ester, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.Formule :C28H50N4O6S3Degré de pureté :Min. 95%Masse moléculaire :634.91 g/molH-QDVH-OH
Please enquire for more information about H-QDVH-OH including the price, delivery time and more detailed product information at the technical inquiry form on this pageMAL-dPEG®4-Glu(OH)-NH-m-dPEG®24
MAL-dPEG®4-Glu(OH)-NH-m-dPEG®24 is a peptide containing polyethylene glycol (PEG) as spacer to alter their pharmacokinetic properties and pharmodynamics.Formule :C72H134N4O35Degré de pureté :Min. 95%Masse moléculaire :1,615.84 g/molGastrin Related Peptide
Gastrin-related peptide is a peptide that is involved in the regulation of the growth of cells. It has been shown to promote cancer cell growth, and may be involved in other cancers such as prostate cancer and neurological disorders. Gastrin related peptide is not active against normal cells, which makes it a potential therapeutic target for cancer treatment.
Formule :C35H46N6O8SDegré de pureté :Min. 95%Masse moléculaire :710.84 g/molH-2kb tetramer peptide - G4
Please enquire for more information about H-2kb tetramer peptide - G4 including the price, delivery time and more detailed product information at the technical inquiry form on this page[D-Leu7]-(-)-Ternatin
Ternatin is a type of molecule known as a natural product or secondary metabolite and can be used as a fat accumulation inhibitor against 3T3-L1 adipocytes. Specifically, it is a cyclic peptide isolated from marine sources. Ternatins have been studied for their potential biological activities, including their anticancer properties. These molecules belong to the broader category of natural products, which are compounds derived from living organisms and often possess interesting biological activities that make them of interest for various applications in medicine, agriculture, and other fields.This product comes as a 1mg vial.Degré de pureté :Min. 95%LGALS1 Human
LGALS1 is a cytokine that is secreted by macrophages in response to LPS, IL-1 and TNF. This cytokine has been shown to promote the secretion of inflammatory cytokines, such as IL-6, IL-8 and TNF-α. LGALS1 is also involved in the recruitment of neutrophils and monocytes to sites of inflammation. LGALS1 has been shown to be involved in regulating the expression of proteins that are involved in cell signaling pathways, including NF-κB and MAPK.Degré de pureté :Min. 95%Lipo-Oxytocin-1
Lipidated Oxytocin analog with long-lasting activities. Product has the following disulfide bonds: Cys1-Cys6 and is available as a 0.5mg vial.Degré de pureté :Min. 95%Urocortin 3 (Mouse, Rat)-EIA Kit (1ea)
Urocortin 3 (Mouse, Rat)-EIA Kit is a first-generation, solid-phase sandwich ELISA kit for the quantitative measurement of mouse and rat urocortin 3. The kit contains all the necessary reagents for performing the assay, including antibodies and standards. The Urocortin 3 (Mouse, Rat)-EIA Kit has been validated with mouse and rat samples and shown to be linear over a wide range of concentrations. The detection limit is 0.5 pg/ml in ELISA plates coated with 100 ng/ml of mouse or rat urocortin 3 antibody.Degré de pureté :Min. 95%Biotin-MAGE-A1 (278-286)
Biotin-MAGE-A1 (278-286) is the N-ter biotinylated version of MAGE-A1 (278-286). Biotin-MAGE-A1 (278-286) can be used in the analysis of antigen-specific T cells. MAGE-A1 protein:
MAGE-A1 (278-286) is an epitope of Melanoma Antigen Gene A1 expressed by tumors of different histological types such as on the surface of breast carcinoma cell and is a Cancer/Testis Antigens (CTA). MAGE-A1 is a tumor antigen expressed in 40% of melanoma and contains epitope for binding HLA-A*02:01 molecules and that are recognized by cytotoxic T cells.
Applications of MAGE-A1 (278-286):
MAGE-A1 (278-286) is used to stimulate specific cytotoxic T cells in PBMCs and to analyze by ELISPOT peptide epitope specificity and cytokine production like IFN-γ. Immunogenicity of MAGE-A1 (278-286) raised the possibility of developing anticancer immunotherapies or vaccinations. MAGE-A1 is also expressed in lung adenocarcinoma and studies suggest that MAGE-A1 may serve to develop Chimeric Antigen Receptor (CAR) T cell therapy using lentiviral vector and show an encouraging tumor-inhibitory efficacy.
Sequence: Biotin-KVLEYVIKVHuman beta-defensin-2 peptide
Human beta-defensin-2 (hBD-2), also known as skin-antimicrobial peptide 1 (SAP1) is a cysteine-rich cationic antimicrobial peptide of 41 amino acids. It was originally isolated from skin cells of psoriasis patients. hBD-2, which belongs to the defensin family, is implicated in the innate immunity thanks to its antimicrobial activity. Thus, β-defensins can play a role at the cutaneous level by limiting the use of antibiotics in severe burns and disease like psoriasis. Moreover, at the pulmonary level, defensins might be involved in the resorption of the infection in cases of cystic fibrosis.
hBD-2 is produced after stimulation of epithelial cells following their contact with some organisms like Gram-negative bacteria and Candida Albicans, fungus or cytokines such as TNF-alpha and IL-1 beta. This antimicrobial activity was shown to be microbicidal at concentrations greater than 1 µM and was lethal for E.Coli and pseudomonas (LD90 : 10 mg/mL) and Candida Albicans (LD90 : 25 mg/mL). Besides its antimicrobial activity, hBD-2 also exhibits proinflammatory properties as chemoattractants for memory T-cells, immature dendritic cells, mast cells and neutrophils.
hBD-2 has also demonstrated inhibitory activity of the voltage-gated potassium channel Kv1.3 at picomolar concentration. Kv1.3 are overexpressed by T-cells in case of autoimmune disorders.Spike Omicron library Biotin
Overlaping biotin-peptide library of Spike Omicron mutant. 15 amino acids per peptide with offset 11. Each peptide is N-ter biotinylated. Purity crude. 1 peptide per well.MAGE-A p248V9 scrambled
SB-peptide offers the scrambled version of MAGE-A p248V9. RQYVELPYV can be used as a negative control of MAGE-A p248V9 studies.
SB-peptide offers also MAGE-A p248V9 (see section MAGE-A p248V9)).
MAGE-A protein:
MAGE-A p248V9, also kwon as multi-MAGE-A (YLEYRQVPV) is an epitope of Melanoma Antigen Gene expressed by tumors of different histological types and is a Cancer/Testis Antigens (CTA). Type of MAGE-A expressed in tumors cells varies according to the type of tumor. Targeting epitopes shared by all MAGE-A antigens would be interest in immunotherapy against a broad spectrum of cancers.
Applications of MAGE-A p248V9 (multi-MAGE-A) :
MAGE-A p248V9 is very useful because it could generate an HLA-A*02:01-restricted CTL response and shared by MAGE-A1,-A2,-A3,-A4,-A6,-A10 and -A12. MAGE-A p248V9 is used to stimulate specific cytotoxic T lymphocytes (CTL) in PBMCs and then to analyze CTL response especially the cytokine production by ELISPOT assay.
Sequence : RQYVELPYVMAGE-A2 (157-166) scrambled
SB-peptide offers the scrambled version of MAGE-A2 (157-166). VLVYFQEIGL can be used as a negative control of MAGE-A2 (157-166) studies. SB-peptide offers also MAGE-A2 (157-166) (see section MAGE-A2 (157-166)). MAGE-A2 protein: MAGE-A2 (157-166) is an epitope of Melanoma Antigen Gene A2 and is one of the most Cancer-Testis Antigens (CTA) overexpressed in tumors of different histological types, such as prostate cancer. Type of MAGE-A expressed in tumors cells varies according to the type of tumor. The expression of MAGE-A2 causes the proliferation of prostate cancer cells and decreases the chemosensitivity. Applications of MAGE-A2 (157-166): MAGE-A2 (157-166) is used to stimulate specific immune response, cytotoxic T cell response and to analyze the cytokine production in PBMCs by ELISPOT assay. In transgenic mouse, it has been demonstrated that MAGE-A2 (157-166) was capable of eliciting a CTL response presented by HLA-A*02:01 molecules. MAGE-A2 (157-166) has been reported to elicit CTL that could lyse tumor cell expressing both HLA-A*02:01 and MAGE-A2 by stimulation of peripheral blood mononuclear cells (PBMCs) with MAGE-A2 (157-166). Sequence : VLVYFQEIGLMAGE-A1 (278-286) scrambled
SB-peptide offers the scrambled version of MAGE-A1 (278-286). ELIVKVYKV can be used as a negative control of MAGE-A1 (278-286) studies.
SB-peptide offers also MAGE-A1 (278-286) (see section MAGE-A1 (278-286)).
MAGE-A1 protein:
MAGE-A1 (278-286) is an epitope of Melanoma Antigen Gene A1 expressed by tumors of different histological types such as on the surface of breast carcinoma cell and is a Cancer/Testis Antigens (CTA). MAGE-A1 is a tumor antigen expressed in 40% of melanoma and contains epitope for binding HLA-A*02:01 molecules and that are recognized by cytotoxic T cells.
Applications of MAGE-A1 (278-286):
MAGE-A1 (278-286) is used to stimulate specific cytotoxic T cells in PBMCs and to analyze by ELISPOT peptide epitope specificity and cytokine production like IFN-γ. Immunogenicity of MAGE-A1 (278-286) raised the possibility of developing anticancer immunotherapies or vaccinations. MAGE-A1 is also expressed in lung adenocarcinoma and studies suggest that MAGE-A1 may serve to develop Chimeric Antigen Receptor (CAR) T cell therapy using lentiviral vector and show an encouraging tumor-inhibitory efficacy.
Sequence : ELIVKVYKVAPYTFGQGTK - SIL Adalimumab signature peptide
APYTFGQGTK peptide is a sequence from light chain of Adalimumab monoclonal antibody. Due to its universal location in Adalimumab antibody, Stable Isotope Labeled (SIL) APYTFGQGTK is used as a specific signature peptide for the quantitation of Adalimumab.Bombesin
Bombesin (BBN) is a 14-amino acid neuropeptide originally isolated from the skin of Bombina bombina. The bombesin-related family comprises three other peptides, the amphibian homologs alytesin and Neuromedin C (NMC), and the mammalian peptide named Gastrin-Releasing Peptide (GRP). Bombesin and bombesin-related peptides are characterized by a region of homology at the carboxy-terminus ending with Gly-His-Leu-Met-NH2, in which resides their biological activity.
Bombesin is active in mammals and affects a broad range of biological functions including smooth muscle contraction, cell growth, blood pressure, plasma glucose, as well as gastric secretions2. These effects are mediated by the interaction of Bombesin peptide with G protein-coupled receptors (GPCRs) called bombesin receptors that are well represented in the gastrointestinal tract and in the central nervous system (CNS).
Bombesin peptide is a potent natural agonist of the mammalian Gastrin Releasing Peptide Receptor (GRPR) also know as bombesin receptor 2 (BB2), whose endogenous ligand is the Gastrin Releasing Peptide (GRP). Bombesin has demonstrated a high affinity for human Gastrin-Releasing Peptide Receptors (hGRPR) in both human cells containing native GRP receptors and murine cells stably expressing human GRP receptors (IC50 = 0.17±0.01 nM and 0.07 ± 0.01 nM, respectively).There is increased interest in targeting the bombesin receptors to explore their roles in pathophysiological processes, and for diagnostic imaging of human cancers over-expressing Gastrin-Releasing Peptide Receptors (GRPR), such as prostate, breast, and small-cell lung carcinoma. Bombesin peptide is investigated as targeting peptide to deliver radiotracers and therapeutic agents into tumors. Moreover, many synthetic agonist analogs of the biologically active COOH terminus of bombesin-related peptides have been synthesized to develop more metabolically stable and selective ligands for Bombesin receptors.DYAMTWVR* - SIL Dupilimab signature peptide qualifier
Secondary SIL peptide for Dupilimab detection and quantification
Spike Omicron library
Overlaping peptide library of Spike Omicron mutant. 15 amino acids per peptide with offset 11. Purity crude. 1 peptide per well.Biotin-SARS-CoV-2 Spike RBD 336-347 peptide
Biotin-SARS-CoV-2 Spike RBD 336-347 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 336-347 peptide. SARS-CoV-2 Spike RBD 336-347 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 336-347 peptide is useful for vaccine development and for structure-activity relationship studies SARS-CoV-2 Spike (S) glycoprotein Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells. With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. SARS-CoV-2 Spike RBD: The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.SARS-CoV-2 Spike RBM 438-458 peptide
SARS-CoV-2 Spike RBM 438-458 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Motif (RBM). SARS-CoV-2 Spike RBM 438-458 peptide is useful for vaccine development and for structure-activity relationship studies SARS-CoV-2 Spike (S) glycoprotein Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells. With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. SARS-CoV-2 Spike RBM: The receptor-binding domain in SARS-CoV-2 Spike protein contains a receptor-binding motif RBM. SARS-CoV-2 Spike RBM is the main functional motif in RBD and allows contacts between the S protein and the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry. SB-PEPTIDE also offers SARS-CoV-2 Spike RBM 438-458 (Biotin-LC) peptideBiotin-SARS-CoV-2 Spike RBD 348-357 peptide
Biotin-SARS-CoV-2 Spike RBD 348-357 peptide is the biotinylated version of SARS-CoV-2 Spike RBD 348-357 peptide. SARS-CoV-2 Spike RBD 348-357 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). Biotin-SARS-CoV-2 Spike RBD 348-357 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.SARS-CoV-2 Spike RBD 352-365 peptide
SARS-CoV-2 Spike RBD 352-365 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 352-365 peptide is useful for vaccine development and for structure-activity relationship studies SARS-CoV-2 Spike (S) glycoprotein Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells. With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. SARS-CoV-2 Spike RBD: The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry. SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 352-365 (Biotin-LC) peptideCOVID-19 variant pack
SARS-CoV-2 Spike (S) glycoprotein: Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein in a class I fusion protein that allows the virus to enter host cells. Variants package available: Some proteins of Sars-CoV-2 are identified as leading targets for COVID-19 therapies. SB-PEPTIDE offers a special pack pre-made peptide libraries of Spike protein including peptides from COVID-19 variants: UK COVID-19 variant B.1.1.7, South Africa COVID-19 variant B.1.351, Brazil COVID-19 variant B.1.1.248. SB-PEPTIDE offers additional plate containing only peptides with Spike S protein mutation of COVID-19 B.1.1.7, B.1.3.5.1 and B.1.1.248 (cited below). Variants package and Spike (S) glycoprotein peptide library can be used for T-cell assays, immune monitoring, antigen specific T-cell stimulation, T-cell expansion and cellular immune response.Biotin-SARS-CoV-2 Spike RBM 450-473 peptide
Biotin-SARS-CoV-2 Spike RBM 450-473 peptide is the biotinylated version of SARS-CoV-2 Spike RBM 450-473 peptide. SARS-CoV-2 Spike RBM 450-473 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Motif (RBM). Biotin-SARS-CoV-2 Spike RBM 450-473 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBM:
The receptor-binding domain in SARS-CoV-2 Spike protein contains a receptor-binding motif RBM. SARS-CoV-2 Spike RBM is the main functional motif in RBD and allows contacts between the S protein and the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.ACTB MS Calibrator (25nmol)
High quality, quantitated heavy/light peptide calibrator for actin beta in Mass Spectroscopy research. Actin beta is an actin isoform and is one of two non-muscle cytoskeletal actins. Actins play roles in cell integrity, structure and motility.Degré de pureté :Min. 95%Lysyl-[Hyp3]-Bradykinin, human
Lysyl-bradykinin is a potent activator of human bradykinin receptors. It is an inhibitor of protein interactions and has a high purity with CAS number 59814-34-8.Formule :C56H85N17O13Degré de pureté :Min. 95%Masse moléculaire :1,204.4 g/molIL 3 Mouse
IL 3 Mouse is a recombinant form of human IL-3 protein with a molecular weight of approximately 30,000 Daltons. IL-3 is an important cytokine in the immune system. It has been shown to play a role in the differentiation and proliferation of T-cells and B-cells. This antibody was generated by immunizing rabbits with purified rat IL-3 protein. The antibody binds to both mouse and human IL-3 proteins with high affinity and specificity.Degré de pureté :Min. 95%Z-Phe-Tyr
CAS :Z-Phe-Tyr is a potent irreversible inhibitor of serine proteases. It binds to the active site of the enzyme and prevents it from performing its function, which is to cleave proteins at specific sites. Z-Phe-Tyr has been shown to be effective against inflammatory bowel disease, but not against other types of diseases such as diabetes mellitus or rheumatoid arthritis. The drug inhibits protease activity and can be used in experimental models to study the molecular mechanisms of inflammation and inflammatory diseases.Formule :C26H26N2O6Degré de pureté :Min. 95%Masse moléculaire :462.49 g/molL-Asparaginase
L-asparaginase is a drug that inhibits the production of asparagine, which is an amino acid that is used in the synthesis of proteins. It has been shown to be effective against T-cell lymphomas, as well as other cancers such as leukemia and colorectal cancer. L-Asparaginase has been shown to inhibit mitochondrial functions in blood samples from patients with prostate cancer. This inhibition may lead to cell death. L-Asparaginase binds to the sephadex G-100 column in a similar manner to sodium citrate and prevents the formation of polymers when it combines with ATP. The enzyme can also be found in primary cells and liver cells, where it causes hypoglycemia by inhibiting glucose production. L-Asparaginase also inhibits dna synthesis by binding to DNA polymerases, preventing their attachment to nucleotide triphosphates (e.g., ATP).
Degré de pureté :Min. 95%Adrenomedullin 2 (Rat)
Adrenomedullin 2, a peptide hormone product, of rat source and has disulfide bond between Cys10-Cys15. Adrenomedullin 2 can be applied as a potent cardiovascular and renal regulator as well as a suppressor for food intake and gastric emptying. This product is available as a 0.1mg vial.Formule :C226H361N75O64S2Degré de pureté :Min. 95%Masse moléculaire :5,216.9 g/mol
![[D-Leu7]-(-)-Ternatin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTNN-4464-V.webp&w=3840&q=75)
![Lysyl-[Hyp3]-Bradykinin, human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FPBK-4191-V.webp&w=3840&q=75)
